Journal
CLINICAL AND VACCINE IMMUNOLOGY
Volume 16, Issue 3, Pages 430-432Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00480-08
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Diseases [RO1AI064562, RO1AI063256]
Ask authors/readers for more resources
We report on the efficacy of the genetically engineered Candida albicans tet-NRG1 strain as an experimental live, attenuated vaccine against disseminated candidiasis in both immunocompetent and immunodeficient mice mostly dependent on T-cell immunity. This experimental vaccination model may represent an important tool to unravel the mechanisms of protective immunity during candidiasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
